Proxy Biomedical Announces Expansion
Irish medical implantable devices manufacturer to double cleanroom facilities as part of expansion that will be completed in the second quarter of 2016.
Proxy Biomedical Ltd., Galway, is adding 3000-ft2 of additional cleanroom space rated to Class 8/ 100,000 to support production of new products, according to a company spokesperson, a move that effectively doubles its cleanroom manufacturing space. Proxy declined to reveal the total amount of investment.
Among the products launched in 2015 which are prompting the expansion are resorbable and non-resorbable biomaterials for vascular indication; Proxy Bio-XT, a proprietary process that reinforces resorbable implants for applications including soft tissue fixation in orthopaedics; and ProTEX Med polypropylene, a custom synthesized resin with a FDA Master File reference.
Proxy’s plastics processing capabilities include compression molding, injection molding, lamination and multi-axial laser processing. The company also has what it describes as a number of systems for resorbable polymer material quality control and characterization.
Related Content
-
Medical-Grade Nylon 6, Nylon 6/66, and PET
DSM Engineering has expanded its Medical Care portfolio of engineering materials for medical devices.
-
Artificial Intelligence Enables Smarter Sourcing
Westfall Technik has adopted Arkestro’s predictive procurement software to wring savings and more reliable deliveries from a historically challenging supply chain.
-
As Currier Grows in Medical Consumables, Blow Molding Is Its ‘Foot in the Door’
Currier Plastics has added substantial capacity recently in both injection and blow molding for medical/pharmaceutical products, including several machines to occupy a new, large clean room.